OncoSynergy, Fighting Brain Cancer as the Family Business

OncoSynergy is a privately-held biotech company with a monoclonal antibody drug platform that is being developed for glioblastoma, the most aggressive form of brain cancer.

There is a great interview in Science Exchange this month with OncoSynergy's founder and CEO Shawn Carbonell, MD, PhD, and his wife, Anne-Marie Carbonell, MD, Vice President of Clinical Development.

In the interview, Shawn and Anne-Marie discuss their work on a drug that could be a game changer for patients with glioblastoma. They also talk about their involvement in the Race for Hope DC - the world's largest brain tumor community event, co-hosted by Accelerate Brain Cancer Cure and the National Brain Tumor Society.  OncoSynergy is the Social Media Sponsor of the 2014 Race for Hope DC.

Click HERE for the full article in Science Exchange.

Share |
March 19, 2015 09:35 PM
Proceeds from the Florida Brain Cancer 5k support this ongoing partnership.
March 18, 2015 04:41 PM
ABC2 is working with Matt de Silva, co-founder of Notable Labs, to advance personalized treatments for brain cancer.

Join us in our fight for a cure!

Twitter